PPSG
MACK
Princeton Portfolio Strategies Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-25,940
| Closed | -$32K | – | 180 |
|
|
2017
Q2 | $32K | Sell |
25,940
-4,150
| -14% | -$5.12K | 0.01% | 163 |
|
|
2017
Q1 | $93K | Sell |
30,090
-3,100
| -9% | -$9.58K | 0.03% | 165 |
|
|
2016
Q4 | $135K | Sell |
33,190
-15,411
| -32% | -$62.7K | 0.04% | 150 |
|
|
2016
Q3 | $309K | Buy |
48,601
+3,740
| +8% | +$23.8K | 0.1% | 124 |
|
|
2016
Q2 | $242K | Hold |
44,861
| – | – | 0.08% | 128 |
|
|
2016
Q1 | $375K | Buy |
44,861
+23,771
| +113% | +$199K | 0.13% | 112 |
|
|
2015
Q4 | $167K | Buy |
21,090
+3,390
| +19% | +$26.8K | 0.06% | 133 |
|
|
2015
Q3 | $151K | Buy |
17,700
+600
| +4% | +$5.12K | 0.06% | 129 |
|
|
2015
Q2 | $211K | Sell |
17,100
-2,500
| -13% | -$30.8K | 0.07% | 133 |
|
|
2015
Q1 | $233K | Sell |
19,600
-1,100
| -5% | -$13.1K | 0.09% | 106 |
|
|
2014
Q4 | $234K | Buy |
+20,700
| New | +$234K | 0.09% | 109 |
|